Akums Drugs & Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 360.80 | 371.25 | 360.47 |
| Operating Expense | 311.03 | 303.38 | 285.28 |
| Net Profit | 27.59 | 41.17 | 50.37 |
| Net Profit Margin | 7.65 | 11.09 | 13.97 |
| Earning Per Share | 1.80 | 2.69 | 3.38 |
| EBIDTA | 48.57 | 67.20 | 77.65 |
| Effective Tax Rate | 16.60 | 19.24 | 18.23 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 360.80 |
| Operating Expense | 311.03 |
| Net Profit | 27.59 |
| Net Profit Margin | 7.65 |
| Earning Per Share | 1.80 |
| EBIDTA | 48.57 |
| Effective Tax Rate | 16.60 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 1,311.78 | 1,444.12 | 1,286.83 |
| Operating Expenses Annual | 1,177.15 | 1,570.78 | 1,044.95 |
| Operating Profit Annual | 262.69 | -51.93 | 193.50 |
| Interest Annual | 15.31 | 18.31 | 13.18 |
| Depreciation | 38.44 | 31.76 | 29.33 |
| Net Profit Annual | 161.00 | -165.45 | 125.43 |
| Tax Annual | 46.84 | 62.52 | 24.89 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 1,311.78 |
| Operating Expenses Annual | 1,177.15 |
| Operating Profit Annual | 262.69 |
| Interest Annual | 15.31 |
| Depreciation | 38.44 |
| Net Profit Annual | 161.00 |
| Tax Annual | 46.84 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 68.96 | 7.23 | 25.49 |
| Cash Flow from Operations | 91 | 247.91 | 94.01 |
| Cash Flow from Investing | -458.84 | -165.44 | -202.17 |
| Cash Flow from Financing | 375.38 | -20.74 | 89.90 |
| Cash Flow at the End | 76.49 | 68.96 | 7.23 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 68.96 |
| Cash Flow from Operations | 91 |
| Cash Flow from Investing | -458.84 |
| Cash Flow from Financing | 375.38 |
| Cash Flow at the End | 76.49 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 20.03 | -2.23 | 26.27 |
| PBIT Margin (%) | 17.01 | -4.50 | 23.94 |
| PBT Margin (%) | 15.90 | -4.25 | 22.12 |
| Net PROFIT Margin (%) | 12.27 | -11.46 | 9.75 |
| Return On Networth / Equity (%) | 13.15 | -69.16 | 92.77 |
| Return On Networth /Employed (%) | 10.70 | -3.92 | 21.17 |
| Return On Assets (%) | 7.73 | -9.97 | 8.58 |
| Total Debt / Equity (X) | 0.13 | 0.91 | 0.57 |
| Asset Turnover Ratio (%) | 0.63 | 0.87 | 0.88 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 20.03 |
| PBIT Margin (%) | 17.01 |
| PBT Margin (%) | 15.90 |
| Net PROFIT Margin (%) | 12.27 |
| Return On Networth / Equity (%) | 13.15 |
| Return On Networth /Employed (%) | 10.70 |
| Return On Assets (%) | 7.73 |
| Total Debt / Equity (X) | 0.13 |
| Asset Turnover Ratio (%) | 0.63 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 340.54 | 298.57 | 253.27 |
| Total Current Assets Annual | 833.18 | 533.24 | 521.08 |
| Non Current Assets Annual | 1,851.73 | 1,562.18 | 1,373.13 |
| Total Shareholders Funds Annual | 2,305.25 | 143.88 | 311.50 |
| Total Assets Annual | 2,684.91 | 2,095.43 | 1,894.21 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 340.54 |
| Total Current Assets Annual | 833.18 |
| Non Current Assets Annual | 1,851.73 |
| Total Shareholders Funds Annual | 2,305.25 |
| Total Assets Annual | 2,684.91 |
EPS (INR)
Expected
9.64
Reported
9.64
Surprise
0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 2.58%
